T-cell lymphoma is a rare cancer that affects the lymphatic system. Learn about the types, signs, symptoms, treatments, and ...

The reactive T cells then exit the skin, re-enter the lymphatic or vascular spaces, and recirculate or undergo the process of natural cell death ... In addition, early-stage MF lesions may ...

Chrisman et al, Updated cutaneous T-cell lymphoma TNMB staging criteria fail to identify patients with Sézary syndrome with low blood burden, Blood (2024). DOI: 10.1182/blood.2023023584 ...

Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma. It is characterized by malignant T-cell lymphocytes in the skin. It presents as patch, plaque, or tumor stage and is ...

The randomised, placebo-controlled FLASH2 trial is expected to enrol nearly 80 patients with early-stage CTCL ... begins enrolling subjects in cutaneous T-cell lymphoma treatment trial" was ...

treatment for up to 12 months in patients with early-stage cutaneous T-cell lymphoma (CTCL). The trial is sponsored by Ellen Kim, MD, Director, Penn Cutaneous Lymphoma Program, Vice Chair of ...

It also covers the Diffuse Large B-Cell Lymphoma therapeutics assessment by product type, stage, route of administration ... or refractory CD30+ cutaneous T- cell lymphoma (CTCL) after at least ...